BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

NovImmune SA 

64 avenue de la Roseraie

Geneva    1211  Switzerland
Phone: 41-22-839-71-41 Fax: 41-22-839-71-42


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology

Segment
Pharmaceuticals





 Company News
NovImmune SA Appoints Andrew J. Oakley As CFO 3/12/2014 6:59:10 AM
NovImmune SA Finishes $66 Million Series B Financing Round 2/18/2014 7:02:37 AM
NovImmune SA Initiates Phase I Clinical Study With First-in-Class Anti-TLR4 Monoclonal Antibody 11/28/2012 9:32:14 AM
NovImmune SA Release: European Commission Awards a EUR 6 Million FP7 Grant to Support Clinical Development of NI-0501 to FIGHT HLH 10/15/2012 10:12:51 AM
NovImmune SA Strengthens Board and Management Team 7/10/2012 10:17:31 AM
Genentech (RHHBY) Initiates First-in-Human Study with NovImmune SA's Anti-IL17 Antibody 12/13/2011 9:14:16 AM
NovImmune SA Initiates a Proof-of-Concept Study in Primary Biliary Cirrhosis (PBC) 9/22/2011 10:00:34 AM
ALGENICS and NovImmune SA Announce a Research Collaboration to Express Fully Human Antibodies Using the Microalgal PTA Cell Line 6/22/2011 10:40:13 AM
NovImmune SA Nominates Klaus Strein as New Member of the Board of Directors 5/25/2011 11:24:01 AM
NovImmune SA Raises Additional CHF 20 Million ($19 Million) 12/17/2010 6:14:20 AM
12